[go: up one dir, main page]

CA2708514A1 - Article and method for focused delivery of therapeutic and/or diagnostic materials - Google Patents

Article and method for focused delivery of therapeutic and/or diagnostic materials Download PDF

Info

Publication number
CA2708514A1
CA2708514A1 CA2708514A CA2708514A CA2708514A1 CA 2708514 A1 CA2708514 A1 CA 2708514A1 CA 2708514 A CA2708514 A CA 2708514A CA 2708514 A CA2708514 A CA 2708514A CA 2708514 A1 CA2708514 A1 CA 2708514A1
Authority
CA
Canada
Prior art keywords
microfiber
extrudate
microfiber extrudate
excitation
active load
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2708514A
Other languages
English (en)
French (fr)
Inventor
Peter D. Gabriele
Michael S. Flemmens
Jeffrey H. Robertson
Andrew Hogan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ARMARK AUTHENTICATION TECHNOLOGIES LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2708514A1 publication Critical patent/CA2708514A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2708514A 2007-12-31 2008-12-23 Article and method for focused delivery of therapeutic and/or diagnostic materials Abandoned CA2708514A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1781507P 2007-12-31 2007-12-31
US61/017,815 2007-12-31
PCT/US2008/088176 WO2009088777A1 (en) 2007-12-31 2008-12-23 Article and method for focused delivery of therapeutic and/or diagnostic materials

Publications (1)

Publication Number Publication Date
CA2708514A1 true CA2708514A1 (en) 2009-07-16

Family

ID=40456354

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2708514A Abandoned CA2708514A1 (en) 2007-12-31 2008-12-23 Article and method for focused delivery of therapeutic and/or diagnostic materials

Country Status (3)

Country Link
EP (1) EP2242481A1 (de)
CA (1) CA2708514A1 (de)
WO (1) WO2009088777A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100291214A1 (en) * 2008-12-23 2010-11-18 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
WO2010151746A2 (en) * 2009-06-26 2010-12-29 Armark Authentication Technologies, Llc Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
CA2962927C (en) 2014-09-29 2023-04-25 Board Of Regents Of The University Of Nebraska Nanofiber structures and methods of synthesis and use thereof
AU2017335828B2 (en) 2016-09-28 2023-07-13 Board Of Regents Of The University Of Nebraska Nanofiber structures and methods of use thereof
US11738116B2 (en) 2017-06-09 2023-08-29 Board Of Regents Of The University Of Nebraska Expanded nanofiber structures comprising electrospun nanofibers and a plurality of holes and methods of making and use thereof
US11427936B2 (en) 2017-09-19 2022-08-30 Board Of Regents Of The University Of Nebraska Methods for producing a nanofiber or microfiber structure
WO2019209762A1 (en) * 2018-04-23 2019-10-31 Board Of Regents Of The University Of Nebraska Nanofiber microspheres and methods of use thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4640035A (en) 1981-09-03 1987-02-03 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Identifying means
US5162074A (en) 1987-10-02 1992-11-10 Basf Corporation Method of making plural component fibers
WO1989002938A1 (en) 1987-10-02 1989-04-06 Hills Research & Development, Inc. Profiled multi-component fibers and method and apparatus for making same
US6088613A (en) * 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
DE4412651A1 (de) * 1994-04-13 1995-10-19 Mueller Schulte Detlef Dr Mittel zur selektiven AIDS Therapie sowie Verfahren zur Herstellung und Verwendung derselben
US5626862A (en) * 1994-08-02 1997-05-06 Massachusetts Institute Of Technology Controlled local delivery of chemotherapeutic agents for treating solid tumors
US20030157187A1 (en) * 1996-12-02 2003-08-21 Angiotech Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory diseases
UA54505C2 (uk) * 1997-04-03 2003-03-17 Гілфорд Фармасьютікалз Інк. Полімери, що біологічно розкладаються, зшиті фосфатами, композиції, вироби і способи для їх виготовлення і використання
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6350464B1 (en) * 1999-01-11 2002-02-26 Guilford Pharmaceuticals, Inc. Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
US6530944B2 (en) * 2000-02-08 2003-03-11 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
WO2002030472A2 (en) * 2000-10-12 2002-04-18 Guilford Pharmaceuticals, Inc. Compositions for release of radiosensitizers, and methods of making and using the same
US7163697B2 (en) * 2001-06-22 2007-01-16 Johns Hopkins University School Of Medicine Biodegradable polymer compositions, compositions and uses related thereto
US6861142B1 (en) 2002-06-06 2005-03-01 Hills, Inc. Controlling the dissolution of dissolvable polymer components in plural component fibers
GB0520902D0 (en) * 2005-10-14 2005-11-23 Chowdhury Dewan F H Nanotubes
US8945598B2 (en) * 2005-12-29 2015-02-03 Cordis Corporation Low temperature drying methods for forming drug-containing polymeric compositions
KR100848930B1 (ko) * 2006-02-24 2008-07-29 (주)에이티젠 양친매성 화합물을 이용한 자성 나노복합체의 제조방법
AU2007249270A1 (en) 2006-05-10 2007-11-22 Armark Authentication Technologies, Inc Extruded filament for microscopic tagging system
CA2652280C (en) * 2006-05-15 2014-01-28 Massachusetts Institute Of Technology Polymers for functional particles

Also Published As

Publication number Publication date
WO2009088777A1 (en) 2009-07-16
EP2242481A1 (de) 2010-10-27

Similar Documents

Publication Publication Date Title
CA2708514A1 (en) Article and method for focused delivery of therapeutic and/or diagnostic materials
Williams et al. Electrospun nanofibers in drug delivery: recent developments and perspectives
Maleki et al. Electrospun core–shell nanofibers for drug encapsulation and sustained release
US8541029B2 (en) Article and method for focused delivery of therapeutic and/or diagnostic materials
De Sousa et al. Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets
Tseng et al. Sustainable release of carmustine from biodegradable poly [(D, L)-lactide-co-glycolide] nanofibrous membranes in the cerebral cavity: in vitro and in vivo studies
TW200946165A (en) Non-invasive systems and methods for in-situ photobiomodulation
CZ20014137A3 (cs) Pouľití biodegradovatelných mikrosférů uvolňujících protirakovinné činidlo
US10568962B2 (en) Hyperthermia targeting compositions, devices, and methods for cancer therapy
Shende et al. Polymeric nanodroplets: an emerging trend in gaseous delivery system
Wu et al. Development and in vitro characterization of drug delivery system of rifapentine for osteoarticular tuberculosis
Nasibova et al. THE MODERN PERSPECTIVES OF NANOMATERIAL APPLICATIONS IN CANCER TREATMENT AND DRUG DELIVERY.
Bukhari et al. Poly lactic-co-glycolic acid nano-carriers for encapsulation and controlled release of hydrophobic drug to enhance the bioavailability and antimicrobial properties
US9642697B2 (en) Breast prosthesis allowing controlled release of drug and production method for same
US20100291214A1 (en) Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
CN1861055A (zh) 含铂类化合物的复方抗癌缓释注射剂
Wu et al. Engineered Hierarchical Microdevices Enable Pre‐Programmed Controlled Release for Postsurgical and Unresectable Cancer Treatment
EP3395830A1 (de) Gelatinepartikel, verfahren zur herstellung von gelatinepartikeln, gelatinepartikelverkapselungszelle und verfahren zur herstellung von gelatinepartikelverkapselungszellen
Norouzi et al. Dual Functional Antibacterial–Antioxidant Core/Shell Alginate/Poly (ε-caprolactone) Nanofiber Membrane: A Potential Wound Dressing
EP4031108B1 (de) Extrudierte depotform mit kontrollierter wirkstofffreisetzung
WO2010151746A2 (en) Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure
Shang et al. Fabrication, characterization, and controlled release of eprinomectin from injectable mesoporous PLGA microspheres
PL242911B1 (pl) Nanoplatforma dostarczania leków na żądanie, sposób jej wytwarzania oraz zastosowanie
US20240122918A1 (en) NanoMesh Drug Delivery for Treatment of Brain Tumors
UĞraŞ et al. Investigation of Cold Atmospheric Plasma Activity in PCL/ZnO Tissue Scaffolding To Be Used in Wound Tissues

Legal Events

Date Code Title Description
FZDE Discontinued